Success Metrics

Clinical Success Rate

75.0%

Based on 9 completed trials

Completion Rate

75%(9/12)

Active Trials

4(13%)

Results Posted

22%(2 trials)

Terminated

3(10%)

Phase Distribution

Ph not_applicable

87%

Ph phase_1

Ph phase_2

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution30 total trials

Phase 1Safety & dosage

2(6.7%)

Phase 2Efficacy & side effects

1(3.3%)

N/ANon-phased studies

27(90.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

52.9%

9 of 17 finished

Non-Completion Rate

47.1%

8 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(13)

Completed(9)

Terminated(8)

Other(1)

Detailed Status

Not yet recruiting9

Completed9

Withdrawn5

Recruiting4

Terminated3

unknown1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

75.0%

Most Advanced

Phase 2

Trials by Phase

Phase 12 (6.7%)

Phase 21 (3.3%)

N/A27 (90.0%)

Trials by Status

recruiting413%

not_yet_recruiting929%

withdrawn516%

unknown13%

terminated310%

completed929%

Recent Activity

4 active trials

Showing 5 of 31

recruitingphase_1

A Study of ASP2246 for People Who Have Movement Problems Caused by Brain Injury After a Stroke

NCT07318714

recruitingnot_applicable

Outcomes of Autologous Bone Marrow-derived Mononuclear Cell Transplantation in the Management of Neurological Sequelae

NCT05293873

View all 31 trials

Clinical Trials (31)

Showing 20 of 31 trialsScroll for more

NCT07318714Phase 1

A Study of ASP2246 for People Who Have Movement Problems Caused by Brain Injury After a Stroke

Recruiting

NCT07306052Not Applicable

Epidural Spinal Cord Stimulation for Restoring Walking in Spinal Cord Injury

Recruiting

NCT06328985Not Applicable

Intermittent Oro-esophageal Tube Feeding in Traumatic Brain Injury Patients

Completed

NCT06102733

Chronic Pelvic Pain in Females and Males

Recruiting

NCT05293873Phase 1

Outcomes of Autologous Bone Marrow-derived Mononuclear Cell Transplantation in the Management of Neurological Sequelae

Completed

NCT06176404Not Applicable

Stellate Ganglion Block in Patients With Cerebral Small Vessel Disease

Completed

NCT06226415Not Applicable

Exploration of Stellate Ganglion Block in Patients With Cerebral Small Vessel Disease

Completed

NCT06328205Not Applicable

Impact of Glossopharyngeal Nerve Block on Swallowing Difficulties Caused by Gastroesophageal Reflux Disease

Not Yet Recruiting

NCT06319638Not Applicable

Efficacy of Stellate Ganglion Block in Traumatic Brain Injury Patients

Not Yet Recruiting

NCT06319495Not Applicable

Stellate Ganglion Block in Patients With Cerebral Small Vessel Disease

Not Yet Recruiting

NCT06319521Not Applicable

Stellate Ganglion Block on Gastroesophageal Reflux Disease

Not Yet Recruiting

NCT06319625Not Applicable

Effectiveness of Stellate Ganglion Block in Patients Diagnosed With Parkinson's Disease

Not Yet Recruiting

NCT06304116Not Applicable

Effect of Lidocaine Block in Traumatic Brain Injury

Not Yet Recruiting

NCT06304142Not Applicable

Effect of Lidocaine Block on Gastroesophageal Reflux Disease

Not Yet Recruiting

NCT06304870Not Applicable

Impact of Blocking the Glossopharyngeal Nerve on Gastroesophageal Reflux Disease

Not Yet Recruiting

NCT06301711Not Applicable

Investigation of Potential Mechanisms in Stellate Ganglion Block in Individuals With Cerebral Small Vessel Disease

Not Yet Recruiting

NCT06304012Not Applicable

Effect of Oral Enteral Nutrition on Severe Traumatic Brain Injury

Completed

NCT06249022Not Applicable

Different Feeding in Traumatic Brain Injury Patients

Recruiting

NCT06248970Not Applicable

The Effect of Intermittent Oro-esophageal Tube Feeding on Severe Traumatic Brain Injury Patients With Tracheostomy

Terminated

NCT06228170Not Applicable

Efficacy of Stellate Ganglion Block in Traumatic Brain Injury Patients

Withdrawn

Drug Details

Intervention Type: OTHER
Total Trials: 31